Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Regeneron Pharmaceuticals - 34 Year Stock Price History | REGN

Historical daily share price chart and data for Regeneron Pharmaceuticals since 1991 adjusted for splits and dividends. The latest closing stock price for Regeneron Pharmaceuticals as of June 27, 2025 is 521.00.
  • The all-time high Regeneron Pharmaceuticals stock closing price was 1198.45 on August 27, 2024.
  • The Regeneron Pharmaceuticals 52-week high stock price is 1211.20, which is 132.5% above the current share price.
  • The Regeneron Pharmaceuticals 52-week low stock price is 476.49, which is 8.5% below the current share price.
  • The average Regeneron Pharmaceuticals stock price for the last 52 weeks is 804.35.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Regeneron Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 621.7379 713.2180 743.7310 483.0700 521.0000 -26.66%
2024 965.6237 902.5050 1198.4500 699.9150 710.3660 -18.90%
2023 781.6642 718.4840 879.2690 678.6140 875.8690 21.73%
2022 660.6900 625.3710 764.2770 546.8380 719.5010 14.25%
2021 556.7856 481.5290 679.0830 445.4990 629.7790 30.72%
2020 530.8904 372.3210 656.3960 335.2530 481.7780 28.66%
2019 342.5594 371.4130 438.3580 272.7060 374.4450 0.53%
2018 350.6986 381.5450 407.3840 283.8150 372.4700 -0.65%
2017 421.3183 378.6530 525.0780 339.8110 374.9240 2.42%
2016 393.4125 515.1260 518.0480 330.1370 366.0780 -32.38%
2015 497.3582 409.0290 590.7670 395.7960 541.3730 32.33%
2014 332.7478 273.8330 433.7510 266.8820 409.1190 49.05%
2013 239.2000 180.7010 315.7570 157.9830 274.4810 60.89%
2012 130.4733 56.2744 187.2230 56.2744 170.5980 208.62%
2011 50.9658 33.7268 71.9910 32.5201 55.2772 68.84%
2010 26.1406 24.5621 33.5971 20.7327 32.7395 35.77%
2009 17.6683 18.6484 24.6718 12.0168 24.1133 31.70%
2008 18.9271 23.4951 24.7017 13.3132 18.3094 -23.98%
2007 20.4928 19.7554 28.5212 13.6223 24.0834 20.33%
2006 16.0708 15.8562 24.2131 11.0893 20.0147 26.23%
2005 8.2753 9.0151 16.7836 4.6172 15.8562 72.64%
2004 10.8053 15.0085 16.6739 6.8311 9.1846 -37.39%
2003 14.7150 19.0374 22.2485 5.8638 14.6694 -20.53%
2002 18.8325 27.8430 29.2292 11.3287 18.4590 -34.27%
2001 28.2992 35.4645 38.8925 20.5432 28.0824 -20.15%
2000 27.2595 12.2786 56.3442 11.4683 35.1684 176.59%
1999 7.7957 7.9156 12.7149 5.5472 12.7149 72.88%
1998 8.1252 8.8505 10.9073 5.8588 7.3547 -13.87%
1997 9.8584 17.0778 19.3216 6.4821 8.5389 -46.90%
1996 16.2180 13.2135 24.5571 11.8423 16.0805 26.47%
1995 9.5748 3.3034 16.4545 3.3034 12.7149 325.01%
1994 7.0163 15.2080 17.2024 2.9917 2.9917 -80.65%
1993 15.4592 11.9669 21.4407 10.9697 15.4573 29.17%
1992 12.9828 18.6983 22.4380 7.9779 11.9669 -33.79%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $56.250B $14.202B
Regeneron is a biotechnology company focused on the discovery, development and commercialization of treatments targeting serious medical conditions. The company's portfolio boasts nine marketed drugs - Eylea, Dupixent, Praluent, Kevzara, Libtayo, Evkeeza, Inmazeb Arcalyst and Zaltrap. The company also developed an antibody cocktail for COVID-19, REGEN-COV. REGEN-COV is a cocktail of two monoclonal antibodies and was designed specifically to block the infectivity of SARS-CoV-2, the virus that causes COVID-19. Regeneron has a collaboration agreement with Roche for the same. While Regeneron has co-developed Eylea with Bayer's HealthCare unit, Praluent was co-developed with Sanofi. Regeneron collaborated with Bayer for the joint development and commercialization of co-formulated combinations of Eylea, rinucumab and nesvacumab for the treatment of ocular diseases or disorders outside the United States.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $216.627B 16.17
Amgen (AMGN) United States $149.014B 13.35
Gilead Sciences (GILD) United States $137.666B 14.30
Vertex Pharmaceuticals (VRTX) United States $113.325B 0.00
Bristol Myers Squibb (BMY) United States $94.326B 6.31
GSK (GSK) United Kingdom $78.987B 9.46
CSL (CSLLY) Australia $74.627B 0.00
Alnylam Pharmaceuticals (ALNY) United States $42.093B 0.00
Argenex SE (ARGX) Netherlands $34.202B 93.36
BioNTech SE (BNTX) Germany $25.655B 0.00
Royalty Pharma (RPRX) United States $20.168B 8.52
Insmed (INSM) United States $18.875B 0.00
Biogen (BIIB) United States $18.474B 7.97
Illumina (ILMN) United States $15.005B 28.47
Genmab (GNMSF) Denmark $13.948B 14.26
Incyte (INCY) United States $13.234B 100.54
Genmab (GMAB) Denmark $13.145B 14.75
Exelixis (EXEL) United States $11.909B 20.22
QIAGEN (QGEN) Netherlands $10.619B 20.66
BioMarin Pharmaceutical (BMRN) United States $10.580B 17.19
Ascendis Pharma (ASND) Denmark $10.528B 0.00
Moderna (MRNA) United States $10.504B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $10.413B 26.59
Exact Sciences (EXAS) United States $10.120B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $8.604B 0.00
Blueprint Medicines (BPMC) United States $8.274B 0.00
Bio-Techne Corp (TECH) United States $8.127B 30.32
Verona Pharma American Depositary Share (VRNA) United Kingdom $7.987B 0.00
Roivant Sciences (ROIV) United Kingdom $7.743B 0.00
Repligen (RGEN) United States $6.942B 77.71
Revolution Medicines (RVMD) United States $6.875B 0.00
Bio-Rad Laboratories (BIO.B) United States $6.805B 23.68
Jazz Pharmaceuticals (JAZZ) Ireland $6.469B 6.35
Halozyme Therapeutics (HALO) United States $6.433B 12.31
Legend Biotech (LEGN) United States $6.364B 0.00
Guardant Health (GH) United States $6.301B 0.00
TG Therapeutics (TGTX) United States $5.829B 153.00
Nuvalent (NUVL) United States $5.722B 0.00
Telix Pharmaceuticals (TLX) Australia $5.412B 0.00
Axsome Therapeutics (AXSM) United States $5.089B 0.00
Alkermes (ALKS) Ireland $4.751B 12.75
Anbio Biotechnology (NNNN) Germany $4.491B 0.00
Akero Therapeutics (AKRO) United States $4.479B 0.00
ADMA Biologics Inc (ADMA) United States $4.335B 32.43
Vaxcyte (PCVX) United States $4.203B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.101B 0.00
Krystal Biotech (KRYS) United States $4.013B 30.93
Rhythm Pharmaceuticals (RYTM) United States $3.991B 0.00
Zealand Pharma (ZLDPF) Denmark $3.985B 0.00
Cytokinetics (CYTK) United States $3.960B 0.00
PTC Therapeutics (PTCT) United States $3.950B 6.87
Zai Lab (ZLAB) China $3.833B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.702B 32.53
Merus (MRUS) Netherlands $3.668B 0.00
Arcellx (ACLX) United States $3.601B 0.00
SpringWorks Therapeutics (SWTX) United States $3.540B 0.00
Avidity Biosciences (RNA) United States $3.499B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.453B 0.00
Protagonist Therapeutics (PTGX) United States $3.452B 74.25
Ascentage Pharma Group - (AAPG) China $3.450B 0.00
Scholar Rock Holding (SRRK) United States $3.400B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.042B 0.00
Metsera (MTSR) United States $3.004B 0.00
Viking Therapeutics (VKTX) United States $2.978B 0.00
Kymera Therapeutics (KYMR) United States $2.873B 0.00
Alvotech (ALVO) Luxembourg $2.756B 15.76
Immunovant (IMVT) United States $2.752B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.632B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.531B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.486B 0.00
ImmunityBio (IBRX) United States $2.383B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.221B 0.00
Ligand Pharmaceuticals (LGND) United States $2.202B 0.00
Apellis Pharmaceuticals (APLS) United States $2.191B 0.00
Twist Bioscience (TWST) United States $2.153B 0.00
Vericel (VCEL) United States $2.101B 1391.00
Bavarian Nordic (BVNRY) Denmark $2.088B 11.03
Denali Therapeutics (DNLI) United States $2.048B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.046B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.045B 0.00
NovoCure (NVCR) Jersey $2.007B 0.00
Apogee Therapeutics (APGE) United States $1.998B 0.00
CG Oncology (CGON) United States $1.978B 0.00
Agios Pharmaceuticals (AGIO) United States $1.938B 0.00
Disc Medicine (IRON) United States $1.888B 0.00
Belite Bio (BLTE) United States $1.880B 0.00
IDEAYA Biosciences (IDYA) United States $1.872B 0.00
Certara (CERT) United States $1.846B 34.48
Harmony Biosciences Holdings (HRMY) United States $1.836B 12.21
Amicus Therapeutics (FOLD) United States $1.826B 197.67
Adaptive Biotechnologies (ADPT) United States $1.791B 0.00
GRAIL (GRAL) United States $1.741B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.695B 0.00
Beam Therapeutics (BEAM) United States $1.689B 0.00
Sarepta Therapeutics (SRPT) United States $1.682B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.638B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.563B 0.00
Vera Therapeutics (VERA) United States $1.444B 0.00
89BIO (ETNB) United States $1.439B 0.00
Biohaven (BHVN) United States $1.439B 0.00
ANI Pharmaceuticals (ANIP) United States $1.419B 14.62
Mesoblast (MESO) Australia $1.395B 0.00
Edgewise Therapeutics (EWTX) United States $1.385B 0.00
Janux Therapeutics (JANX) United States $1.370B 0.00
Celldex Therapeutics (CLDX) United States $1.347B 0.00
Travere Therapeutics (TVTX) United States $1.312B 0.00
Structure Therapeutics (GPCR) United States $1.209B 0.00
CureVac (CVAC) Germany $1.207B 5.85
Dynavax Technologies (DVAX) United States $1.190B 70.79
Viridian Therapeutics (VRDN) United States $1.169B 0.00
BGM Group (BGM) China $1.164B 0.00
MannKind (MNKD) United States $1.143B 23.50
Niagen Bioscience (NAGE) United States $1.120B 158.00
Liquidia Technologies (LQDA) United States $1.120B 0.00
Pacira BioSciences (PCRX) United States $1.087B 10.34
AbCellera Biologics (ABCL) Canada $1.077B 0.00
WAVE Life Sciences (WVE) Singapore $1.038B 0.00
Novavax (NVAX) United States $1.032B 2.40
Intellia Therapeutics (NTLA) United States $0.990B 0.00
Geron (GERN) United States $0.949B 0.00
NeoGenomics (NEO) United States $0.924B 0.00
Spyre Therapeutics (SYRE) United States $0.917B 0.00
Mineralys Therapeutics (MLYS) United States $0.894B 0.00
Pharvaris (PHVS) Netherlands $0.889B 0.00
Nurix Therapeutics (NRIX) United States $0.887B 0.00
Oric Pharmaceuticals (ORIC) United States $0.879B 0.00
MiMedx (MDXG) United States $0.877B 21.21
Praxis Precision Medicines (PRAX) United States $0.876B 0.00
Zymeworks (ZYME) United States $0.868B 0.00
LENZ Therapeutics (LENZ) United States $0.849B 0.00
CorMedix Inc (CRMD) United States $0.848B 56.82
Oculis Holding AG (OCS) Switzerland $0.845B 0.00
Arcus Biosciences (RCUS) United States $0.842B 0.00
Anavex Life Sciences (AVXL) United States $0.809B 0.00
Cogent Biosciences (COGT) United States $0.808B 0.00
ArriVent BioPharma (AVBP) United States $0.784B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.778B 0.00
Pharming Group (PHGUF) Netherlands $0.772B 0.00
Immunome (IMNM) United States $0.763B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.760B 0.00
UniQure (QURE) Netherlands $0.759B 0.00
Pharming Group (PHAR) Netherlands $0.749B 0.00
Replimune (REPL) United States $0.719B 0.00
Vir Biotechnology (VIR) United States $0.715B 0.00
Sionna Therapeutics (SION) United States $0.699B 0.00
Gyre Therapeutics (GYRE) United States $0.696B 185.50
Phathom Pharmaceuticals (PHAT) United States $0.680B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.663B 0.00
AnaptysBio (ANAB) United States $0.660B 0.00
Immatics (IMTX) Germany $0.660B 0.00
Trevi Therapeutics (TRVI) United States $0.659B 0.00
Nuvation Bio (NUVB) United States $0.657B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.656B 0.00
GH Research (GHRS) Ireland $0.647B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Stoke Therapeutics (STOK) United States $0.635B 14.72
Sana Biotechnology (SANA) United States $0.634B 0.00
Urogen Pharma (URGN) United States $0.622B 0.00
Cidara Therapeutics (CDTX) United States $0.620B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.615B 0.00
Arbutus Biopharma (ABUS) United States $0.599B 0.00
Upstream Bio (UPB) United States $0.588B 0.00
Castle Biosciences (CSTL) United States $0.588B 39.90
Sage Therapeutics (SAGE) United States $0.573B 0.00
Dianthus Therapeutics (DNTH) United States $0.567B 0.00
Iovance Biotherapeutics (IOVA) United States $0.564B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.554B 0.00
Arvinas (ARVN) United States $0.550B 0.00
Keros Therapeutics (KROS) United States $0.548B 0.00
Tango Therapeutics (TNGX) United States $0.543B 0.00
Maze Therapeutics (MAZE) United States $0.531B 0.00
MeiraGTx Holdings (MGTX) United States $0.531B 0.00
Opthea (OPT) Australia $0.525B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.501B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.495B 0.00
Kura Oncology (KURA) United States $0.491B 0.00
Myriad Genetics (MYGN) United States $0.484B 0.00
Tyra Biosciences (TYRA) United States $0.483B 0.00
Bicara Therapeutics (BCAX) United States $0.475B 0.00
Celcuity (CELC) United States $0.475B 0.00
Abivax SA (ABVX) France $0.470B 0.00
Septerna (SEPN) United States $0.468B 0.00
Cullinan Therapeutics (CGEM) United States $0.458B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.453B 0.00
Fortrea Holdings (FTRE) United States $0.451B 12.45
Cytek Biosciences (CTKB) United States $0.450B 0.00
ATyr Pharma (ATYR) United States $0.448B 0.00
Kamada (KMDA) Israel $0.443B 26.59
Mereo BioPharma Group - (MREO) United Kingdom $0.423B 0.00
REGENXBIO (RGNX) United States $0.421B 0.00
Precigen (PGEN) United States $0.419B 0.00
Rapport Therapeutics (RAPP) United States $0.417B 0.00
PureTech Health (PRTC) United States $0.412B 0.00
Zenas BioPharma (ZBIO) United States $0.401B 0.00
Fulcrum Therapeutics (FULC) United States $0.383B 0.00
ITeos Therapeutics (ITOS) United States $0.381B 0.00
Eton Pharmaceuticals (ETON) United States $0.376B 0.00
Rezolute (RZLT) United States $0.372B 0.00
Erasca (ERAS) United States $0.371B 0.00
Vigil Neuroscience (VIGL) United States $0.371B 0.00
Tectonic Therapeutic (TECX) United States $0.370B 0.00
Solid Biosciences (SLDB) United States $0.366B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.362B 0.00
MBX Biosciences (MBX) United States $0.359B 0.00
Compass Therapeutics (CMPX) United States $0.354B 0.00
Northwest Biotherapeutics (NWBO) United States $0.349B 0.00
Emergent Biosolutions (EBS) United States $0.345B 0.00
Terns Pharmaceuticals (TERN) United States $0.335B 0.00
Absci (ABSI) United States $0.334B 0.00
XOMA Royalty (XOMA) United States $0.329B 0.00
Humacyte (HUMA) United States $0.329B 0.00
Prothena (PRTA) Ireland $0.327B 0.00
Amarin (AMRN) Ireland $0.325B 0.00
Citius Oncology (CTOR) United States $0.322B 0.00
Prime Medicine (PRME) United States $0.318B 0.00
Olema Pharmaceuticals (OLMA) United States $0.316B 0.00
Aura Biosciences (AURA) United States $0.316B 0.00
Astria Therapeutics (ATXS) United States $0.314B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.312B 0.00
Lifecore Biomedical (LFCR) United States $0.303B 0.00
Benitec Biopharma (BNTC) United States $0.298B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.297B 0.00
Atea Pharmaceuticals (AVIR) United States $0.295B 0.00
Abeona Therapeutics (ABEO) United States $0.294B 0.00
Inventiva S.A (IVA) France $0.292B 0.00
Aardvark Therapeutics (AARD) United States $0.291B 0.00
Ocugen (OCGN) United States $0.287B 0.00
Gossamer Bio (GOSS) United States $0.284B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.283B 57.50
Vanda Pharmaceuticals (VNDA) United States $0.282B 0.00
Cartesian Therapeutics (RNAC) United States $0.277B 0.00
Alpha Teknova (TKNO) United States $0.273B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.270B 0.00
Foghorn Therapeutics (FHTX) United States $0.270B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.269B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.265B 0.00
Annexon (ANNX) United States $0.264B 0.00
Entrada Therapeutics (TRDA) United States $0.262B 8.53
Allogene Therapeutics (ALLO) United States $0.258B 0.00
Inozyme Pharma (INZY) United States $0.258B 0.00
Candel Therapeutics (CADL) United States $0.246B 0.00
Third Harmonic Bio (THRD) United States $0.245B 0.00
Palvella Therapeutics (PVLA) United States $0.244B 0.00
DBV Technologies S.A (DBVT) France $0.243B 0.00
Sagimet Biosciences (SGMT) United States $0.241B 0.00
Prima BioMed (IMMP) Australia $0.240B 0.00
MaxCyte (MXCT) United States $0.234B 0.00
Neurogene (NGNE) United States $0.230B 0.00
Tvardi Therapeutics (TVRD) United States $0.230B 0.00
Verastem (VSTM) United States $0.228B 0.00
Semper Paratus Acquisition (TVGN) United States $0.228B 0.00
Adherex Technologies (FENC) United States $0.228B 0.00
BioStem Technologies (BSEM) $0.226B 9.18
ProQR Therapeutics (PRQR) Netherlands $0.215B 0.00
Adocia (ADOCY) France $0.213B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.213B 0.00
I-Mab (IMAB) United States $0.210B 0.00
Cardiff Oncology (CRDF) United States $0.210B 0.00
Inhibrx Biosciences (INBX) United States $0.209B 0.12
Monopar Therapeutics (MNPR) United States $0.205B 0.00
ScPharmaceuticals (SCPH) United States $0.204B 0.00
Design Therapeutics (DSGN) United States $0.203B 0.00
AC Immune (ACIU) Switzerland $0.202B 0.00
Codexis (CDXS) United States $0.198B 0.00
Kodiak Sciences (KOD) United States $0.195B 0.00
SELLAS Life Sciences (SLS) United States $0.195B 0.00
CARGO Therapeutics (CRGX) United States $0.193B 0.00
Editas Medicine (EDIT) United States $0.191B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.191B 0.00
EnGene Holdings (ENGN) Canada $0.187B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.187B 0.00
CytomX Therapeutics (CTMX) United States $0.181B 4.69
GENFIT S.A (GNFT) France $0.180B 0.00
Innate Pharma S.A (IPHA) France $0.171B 0.00
Ventyx Biosciences (VTYX) United States $0.167B 0.00
Puma Biotechnology (PBYI) United States $0.165B 4.32
DiaMedica Therapeutics (DMAC) United States $0.165B 0.00
Spero Therapeutics (SPRO) United States $0.164B 0.00
Alumis (ALMS) United States $0.164B 0.00
Bright Minds Biosciences (DRUG) United States $0.164B 0.00
Voyager Therapeutics (VYGR) United States $0.164B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.161B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.160B 0.00
Nuvectis Pharma (NVCT) United States $0.158B 0.00
Anika Therapeutics (ANIK) United States $0.154B 0.00
Molecular Partners AG (MOLN) Switzerland $0.152B 0.00
Instil Bio (TIL) United States $0.151B 0.00
BioAge Labs (BIOA) United States $0.151B 0.00
Compugen (CGEN) Israel $0.148B 0.00
Alector (ALEC) United States $0.148B 0.00
Alpha Cognition (ACOG) Canada $0.146B 0.00
Kyverna Therapeutics (KYTX) United States $0.142B 0.00
Rapt Therapeutics (RAPT) United States $0.139B 0.00
Black Diamond Therapeutics (BDTX) United States $0.134B 39.17
Vor Biopharma (VOR) $0.132B 0.00
Agenus (AGEN) United States $0.131B 0.00
Skye Bioscience (SKYE) United States $0.127B 0.00
Immuneering (IMRX) United States $0.127B 0.00
Elicio Therapeutics (ELTX) United States $0.126B 0.00
Sangamo Therapeutics (SGMO) United States $0.126B 0.00
Seer (SEER) United States $0.125B 0.00
INmune Bio (INMB) United States $0.123B 0.00
Neumora Therapeutics (NMRA) United States $0.122B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.122B 0.00
Greenwich LifeSciences (GLSI) United States $0.120B 0.00
23andMe Holding (MEHCQ) United States $0.120B 0.00
Fate Therapeutics (FATE) United States $0.119B 0.00
Nkarta (NKTX) United States $0.118B 0.00
Caribou Biosciences (CRBU) United States $0.117B 0.00
Actuate Therapeutics (ACTU) United States $0.117B 0.00
Genelux (GNLX) United States $0.113B 0.00
BioHarvest Sciences (BHST) Canada $0.110B 0.00
Theratechnologies (THTX) Canada $0.108B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.107B 0.00
Contineum Therapeutics (CTNM) United States $0.106B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.104B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.104B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.099B 0.00
C4 Therapeutics (CCCC) United States $0.099B 0.00
Tenaya Therapeutics (TNYA) United States $0.099B 0.00
HilleVax (HLVX) United States $0.099B 0.00
BeyondSpring (BYSI) United States $0.099B 0.00
Coya Therapeutics (COYA) United States $0.098B 0.00
TuHURA Biosciences (HURA) United States $0.097B 0.00
IO Biotech (IOBT) Denmark $0.095B 0.00
Whitehawk Therapeutics (WHWK) United States $0.091B 0.00
Adagene (ADAG) China $0.090B 0.00
Entera Bio (ENTX) Israel $0.090B 0.00
Nautilus Biotechnology (NAUT) United States $0.088B 0.00
Invivyd (IVVD) United States $0.087B 0.00
EXoZymes (EXOZ) United States $0.087B 0.00
Elutia (ELUT) United States $0.086B 0.00
Coherus Oncology (CHRS) United States $0.086B 0.00
XBiotech (XBIT) United States $0.085B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.085B 0.00
OKYO Pharma (OKYO) $0.083B 0.00
Jasper Therapeutics (JSPR) United States $0.082B 0.00
Forte Biosciences (FBRX) United States $0.081B 0.00
Cellectis S.A (CLLS) France $0.081B 0.00
Climb Bio (CLYM) United States $0.080B 0.00
Cabaletta Bio (CABA) United States $0.080B 0.00
Seres Therapeutics (MCRB) United States $0.079B 0.00
TScan Therapeutics (TCRX) United States $0.079B 0.00
TELA Bio (TELA) United States $0.078B 0.00
Inovio Pharmaceuticals (INO) United States $0.077B 0.00
Pliant Therapeutics (PLRX) United States $0.077B 0.00
Zura Bio (ZURA) United States $0.072B 0.00
Oncolytics Biotech (ONCY) Canada $0.071B 0.00
Quince Therapeutics (QNCX) United States $0.070B 0.00
Biomea Fusion (BMEA) United States $0.068B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.068B 0.00
Immunic (IMUX) United States $0.067B 0.00
Ikena Oncology (IKNA) United States $0.066B 0.00
MediciNova (MNOV) United States $0.065B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.065B 0.00
IGM Biosciences (IGMS) United States $0.065B 0.00
PDS Biotechnology (PDSB) United States $0.064B 0.00
Quantum Biopharma (QNTM) Canada $0.063B 0.00
Alto Neuroscience (ANRO) United States $0.063B 0.00
Sutro Biopharma (STRO) United States $0.062B 0.00
Akoya Biosciences (AKYA) United States $0.062B 0.00
Immix Biopharma (IMMX) United States $0.060B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.060B 0.00
Clearside Biomedical (CLSD) United States $0.060B 0.00
Repare Therapeutics (RPTX) Canada $0.060B 0.00
Opus Genetics (IRD) United States $0.058B 0.00
VistaGen Therapeutics (VTGN) United States $0.057B 0.00
Adlai Nortye (ANL) Cayman Islands $0.057B 0.00
ZIVO Bioscience (ZIVO) United States $0.057B 0.00
Genenta Science S.p.A (GNTA) Italy $0.057B 0.00
Senti Biosciences (SNTI) United States $0.056B 0.00
Earth Science Tech (ETST) United States $0.056B 0.00
Cue Biopharma (CUE) United States $0.056B 0.00
Connect Biopharma Holdings (CNTB) United States $0.056B 0.00
InflaRx (IFRX) Germany $0.054B 0.00
Fortress Biotech (FBIO) United States $0.054B 0.00
Oncobiologics (OTLK) United States $0.054B 0.00
CervoMed (CRVO) United States $0.053B 0.00
Adicet Bio (ACET) United States $0.052B 0.00
Renovaro (RENB) United States $0.050B 0.00
Kalaris Therapeutics (KLRS) United States $0.049B 0.00
Adverum Biotechnologies (ADVM) United States $0.048B 0.00
Precision BioSciences (DTIL) United States $0.048B 0.00
Atara Biotherapeutics (ATRA) United States $0.047B 0.00
RenovoRx (RNXT) United States $0.047B 0.00
VTv Therapeutics (VTVT) United States $0.046B 0.00
Applied Therapeutics (APLT) United States $0.046B 0.00
Werewolf Therapeutics (HOWL) United States $0.046B 0.00
Celularity (CELU) United States $0.044B 0.00
Aligos Therapeutics (ALGS) United States $0.044B 0.00
ABVC BioPharma (ABVC) United States $0.044B 0.00
Scilex Holding (SCLX) United States $0.042B 0.00
Grace Therapeutics (GRCE) Canada $0.041B 0.00
Shattuck Labs (STTK) United States $0.041B 0.00
Annovis Bio (ANVS) United States $0.040B 0.00
Pluri (PLUR) Israel $0.040B 0.00
Medicus Pharma (MDCX) United States $0.039B 0.00
PepGen (PEPG) United States $0.038B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.037B 0.00
Exicure (XCUR) United States $0.037B 0.00
Radiopharm Theranostics - (RADX) Australia $0.037B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.037B 0.00
Mersana Therapeutics (MRSN) United States $0.036B 0.00
Artiva Biotherapeutics (ARTV) United States $0.036B 0.00
Xilio Therapeutics (XLO) United States $0.035B 0.00
Alterity Therapeutics - (ATHE) Australia $0.035B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.034B 0.00
Lantern Pharma (LTRN) United States $0.034B 0.00
Clene (CLNN) United States $0.034B 0.00
AN2 Therapeutics (ANTX) United States $0.033B 0.00
Rein Therapeutics (RNTX) United States $0.033B 0.00
Kezar Life Sciences (KZR) United States $0.032B 0.00
OnKure Therapeutics (OKUR) United States $0.032B 0.00
Estrella Immunopharma (ESLA) United States $0.032B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.032B 0.00
Rani Therapeutics Holdings (RANI) United States $0.032B 0.00
Eyenovia (EYEN) United States $0.031B 0.00
CAMP4 Therapeutics (CAMP) United States $0.031B 0.00
Dyadic (DYAI) United States $0.030B 0.00
KALA BIO (KALA) United States $0.030B 0.00
MiNK Therapeutics (INKT) United States $0.028B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.027B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.026B 0.00
Femasys (FEMY) United States $0.025B 0.00
Tenax Therapeutics (TENX) United States $0.024B 0.00
Lisata Therapeutics (LSTA) United States $0.024B 0.00
FibroBiologics (FBLG) United States $0.024B 0.00
Curis (CRIS) United States $0.023B 0.00
Boundless Bio (BOLD) United States $0.023B 0.00
BioAtla (BCAB) United States $0.022B 0.00
Chemomab Therapeutics (CMMB) Israel $0.022B 0.00
ALX Oncology Holdings (ALXO) United States $0.022B 0.00
Ovid Therapeutics (OVID) United States $0.021B 0.00
Elevation Oncology (ELEV) United States $0.021B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.021B 0.00
Dare Bioscience (DARE) United States $0.021B 0.00
Passage Bio (PASG) United States $0.021B 0.00
Cadrenal Therapeutics (CVKD) United States $0.021B 0.00
Generation Bio (GBIO) United States $0.020B 0.00
BRIACELL THERAP (BCTX) Canada $0.020B 0.00
CalciMedica (CALC) United States $0.020B 0.00
Longeveron (LGVN) United States $0.020B 0.00
Aytu BioPharma (AYTU) United States $0.019B 0.00
Cognition Therapeutics (CGTX) United States $0.019B 0.00
Q32 Bio (QTTB) United States $0.018B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.018B 0.00
Cingulate (CING) United States $0.017B 0.00
Gelteq (GELS) Australia $0.017B 0.00
Promis Neurosciences (PMN) Canada $0.016B 0.00
SAB Biotherapeutics (SABS) United States $0.016B 0.00
Advanced Biomed (ADVB) United States $0.015B 0.00
HOOKIPA Pharma (HOOK) United States $0.015B 0.00
Allarity Therapeutics (ALLR) United States $0.015B 0.00
Hoth Therapeutics (HOTH) United States $0.015B 0.00
Lexaria Bioscience (LEXX) Canada $0.015B 0.00
GeoVax Labs (GOVX) United States $0.015B 0.00
Synlogic (SYBX) United States $0.015B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.014B 0.00
Rallybio (RLYB) United States $0.014B 0.00
Beyond Air (XAIR) United States $0.014B 0.00
UNITY Biotechnology (UBX) United States $0.013B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.013B 0.00
Imunon (IMNN) United States $0.013B 0.00
Abpro Holdings (ABP) United States $0.013B 0.00
NextCure (NXTC) United States $0.013B 0.00
IBio (IBIO) United States $0.012B 0.00
MetaVia (MTVA) United States $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.012B 0.00
Athira Pharma (ATHA) United States $0.012B 0.00
BioCardia (BCDA) United States $0.011B 0.00
Bionano Genomics (BNGO) United States $0.011B 0.00
Equillium (EQ) United States $0.011B 0.00
Sensei Biotherapeutics (SNSE) United States $0.011B 0.00
Leap Therapeutics (LPTX) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Bolt Biotherapeutics (BOLT) United States $0.011B 0.00
BioXcel Therapeutics (BTAI) United States $0.011B 0.00
X4 Pharmaceuticals (XFOR) United States $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.010B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.010B 0.00
Cyclerion Therapeutics (CYCN) United States $0.010B 0.00
Aprea Therapeutics (APRE) United States $0.009B 0.00
GT Biopharma (GTBP) United States $0.009B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
LakeShore Biopharma (LSB) China $0.009B 0.00
BioAffinity Technologies (BIAF) United States $0.008B 0.00
Synaptogenix (SNPX) United States $0.008B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
Intensity Therapeutics (INTS) United States $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.008B 0.00
Jade Biosciences (JBIO) United States $0.008B 0.00
Apollomics (APLM) United States $0.007B 0.00
Evogene (EVGN) Israel $0.007B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.007B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
HCW Biologics (HCWB) United States $0.006B 0.00
IN8bio (INAB) United States $0.006B 0.00
Novogen (KZIA) Australia $0.006B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.006B 0.00
GENPREX (GNPX) United States $0.006B 0.00
Arcadia Biosciences (RKDA) United States $0.006B 0.00
Portage Biotech (PRTG) $0.006B 0.00
Biofrontera (BFRI) United States $0.006B 0.00
Pasithea Therapeutics (KTTA) United States $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
Avalon GloboCare (ALBT) United States $0.005B 0.00
CNS Pharmaceuticals (CNSP) United States $0.005B 0.00
Tharimmune (THAR) United States $0.005B 0.00
Mainz Biomed (MYNZ) Germany $0.005B 0.00
180 Life Sciences (ATNF) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.005B 0.00
Mustang Bio (MBIO) United States $0.004B 0.00
Soligenix (SNGX) United States $0.004B 0.00
Moleculin Biotech (MBRX) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Polyrizon (PLRZ) Israel $0.004B 0.00
Dermata Therapeutics (DRMA) United States $0.004B 0.00
VivoSim Labs (VIVS) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.004B 0.00
Adial Pharmaceuticals (ADIL) United States $0.004B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
Purple Biotech (PPBT) Israel $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
GRI Bio (GRI) United States $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Alzamend Neuro (ALZN) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
NuCana (NCNA) United Kingdom $0.001B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00